Top compounds associated with response to RP11-249L12.1


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Teniposide CTRPv2 pan-cancer AAC 0.027 0.5
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC -0.049 0.5
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA Zebularine CTRPv2 pan-cancer AAC -0.023 0.5
mRNA FSC231 CTRPv2 pan-cancer AAC -0.048 0.5
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.048 0.5
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.5
Download CSV